HomeStock ScreenerYatharth HospitalIntrinsic Value

Yatharth Hospital Intrinsic Value

Yatharth Hospital (YATHARTH) median intrinsic value is ₹341.85 from 9 valuation models (range ₹228–₹570), vs current price ₹1139.50 — -70.0% downside (Trading Above Calculated Value), margin of safety -100.0%. For current market price and key ratios, visit Yatharth Hospital stock price NSE.

Market Price (CMP)
₹1139.50
Primary Intrinsic Value
₹341.85
Market Cap
₹109.4K Cr
-70.0% Downside
Median Value
₹341.85
Value Range
₹228 - ₹570
Assessment
Trading Above Calculated Value
Safety Margin
-100.0%

YATHARTH Valuation Methods Summary — DCF, Graham Number & P/E

Yatharth Hospital intrinsic value across 9 models vs current price ₹1139.50 — upside/downside and value range per method. Check YATHARTH company valuation to track the company's total market size over time.

Method Type Intrinsic Value Range Upside/Downside Details
P/E Based Valuation earnings ₹341.85 ₹273.48 - ₹410.22 -70.0% EPS: ₹19.72, Sector P/E: 12x
Book Value Method asset ₹227.90 ₹205.11 - ₹250.69 -80.0% Book Value/Share: ₹185.52, P/B: 1.0x
Revenue Multiple Method revenue ₹341.85 ₹307.67 - ₹376.04 -70.0% Revenue/Share: ₹145.42, P/S: 0.8x
EBITDA Multiple Method earnings ₹455.80 ₹410.22 - ₹501.38 -60.0% EBITDA: ₹348.00Cr, EV/EBITDA: 6x
Simple DCF (5Y) dcf ₹455.80 ₹364.64 - ₹546.96 -60.0% CF Growth: 15.0%, Discount: 15%
PEG Ratio Method growth ₹341.85 ₹307.67 - ₹376.04 -70.0% EPS Growth: 8.0%, Fair P/E: 6.4x
Growth Adjusted P/E growth ₹341.85 ₹307.67 - ₹376.04 -70.0% Revenue Growth: 6.0%, Adj P/E: 8.2x
ROE Based Valuation profitability ₹569.75 ₹512.77 - ₹626.73 -50.0% ROE: 10.1%, P/E Multiple: 12x
Graham Defensive Method conservative ₹341.85 ₹307.67 - ₹376.04 -70.0% EPS: ₹19.72, BVPS: ₹185.52
Method Types: Earnings Asset DCF Growth Dividend Conservative

YATHARTH Intrinsic Value vs Market Price — All Valuation Models

Yatharth Hospital fair value range ₹228–₹570 vs current market price ₹1139.50 across 9 valuation models. See Yatharth Hospital P/B ratio trends to compare market price against book value per share.

YATHARTH Intrinsic Value Analysis — Undervalued or Overvalued?

Yatharth Hospital median intrinsic value ₹341.85, current price ₹1139.50 — Trading Above Calculated Value by 70.0%, margin of safety -100.0%.

What is the intrinsic value of YATHARTH?

Based on our comprehensive analysis using 9 different valuation methods, the estimated intrinsic value of Yatharth Hospital (YATHARTH) is ₹341.85 (median value). With the current market price of ₹1139.50, this represents a -70.0% variance from our estimated fair value.

The valuation range spans from ₹227.90 to ₹569.75, indicating ₹227.90 - ₹569.75.

Is YATHARTH undervalued or overvalued?

Based on our multi-method analysis, Yatharth Hospital (YATHARTH) appears to be trading above calculated value by approximately 70.0%.

YATHARTH Financial Health — Key Ratios vs Industry Benchmarks

Yatharth Hospital financial ratios — ROE, debt-to-equity, profit margins and liquidity vs industry benchmarks and their impact on intrinsic value.

Financial Metric Current Value Industry Benchmark Assessment Impact on Valuation
Current Ratio 2.45 Industry Standard: 2.0+ Above 2.0 Measures short-term liquidity capacity
Return on Equity 10.1% Industry Standard: 15%+ Above 10% Measures shareholder return efficiency
Operating Margin 23.0% Industry Standard: 20%+ Above 20% Indicates operational efficiency level
Asset Turnover Ratio 0.61x Industry Standard: 1.0x+ Above 0.5x Measures asset utilization efficiency

YATHARTH Cash Flow Quality — Operating & Free Cash Flow

Yatharth Hospital operating cash flow, free cash flow, quality rating and sustainability score by period — key inputs to DCF intrinsic value calculation.

Period Operating Cash Flow Free Cash Flow Cash Flow Quality Sustainability Score
March 2025 ₹150 Cr ₹-60 Cr Positive Operating Cash Flow 6/10
March 2024 ₹-3 Cr ₹-116 Cr Negative Cash Flow 3/10
March 2023 ₹64 Cr ₹54 Cr Positive Free Cash Flow 8/10
March 2022 ₹60 Cr ₹34 Cr Positive Free Cash Flow 8/10
March 2021 ₹44 Cr ₹34 Cr Positive Free Cash Flow 8/10